1/1
Export Ready

HERTRAZ 440 MG (TRASTUZUMAB INJECTION)

Sold by Trigen Enterprises · Distributor, Exporter, Importer, Wholesaler · Mumbai, Maharashtra, India

Price
₹ 164.37 /Centimetre
In stock
MRP ₹ 619.65
Inclusive of all taxes
You Save: ₹ 455.28
Minimum order: 1 Centimetre

Export Snapshot

MOQ
1 Centimetre
Lead time
On request
Packaging
Standard export packaging
Shelf life / longevity
As per product specification
HSN Code
30021500
Origin
India
Port of dispatch
On request
Export markets served
Global markets
Values shown are for Trigen Enterprises.
Suitable for

Importers · Distributors · Wholesalers

Know your supplier

Trigen Enterprises is a Distributor, Exporter, Importer, Wholesaler based in Mumbai Maharashtra India.

Mumbai Dispatch on request Verified seller
Trigen Enterprises logo

Trigen Enterprises

Distributor, Exporter, Importer, Wholesaler · Mumbai, Maharashtra, India

Trigen Enterprises is a reputable pharmaceutical distributor based in Mumbai, operating since 2014. As authorized distributors and stockists for leading pharmaceutical companies such as Reliance Life Science, Mylan, Biocon, and Hetero Trigen Enterprises specializes in the oncology segment, offering high-quality products to healthcare providers. The company also engages in government tenders, including IHNS Ashvini, ensuring the availability of essential medications across sectors

Registered address: Mumbai, India. Industry: Healthcare, Medical Supplies & Pharmaceuticals > Drugs & Pharmaceuticals.

Established
2014
Employees
1–10
GST
27AJVPG8610J1ZQ
IEC code
Not shared
Export markets
Global markets
GlobalLinker Member Since
Oct 2024
Turnover
$1 MM - $2 MM
Incorporation Type
On request
Certifications & Awards
Product details

What are the specifications of this product?

Overview

HERTRAZ 440 MG (Trastuzumab Injection) is a targeted biopharmaceutical product used in the treatment of HER2-positive breast cancer and gastric cancers. Trastuzumab is a monoclonal antibody that specifically binds to the HER2 receptors on the surface of cancer cells, inhibiting proliferation and inducing immune-mediated cytotoxicity. This injection is designed for intravenous administration under the guidance of oncologists and healthcare professionals in clinical and hospital settings. HERTRAZ 440 MG plays a critical role in improving survival rates and reducing tumor progression in eligible patients with HER2 overexpressing tumors. The product is manufactured under stringent quality control and complies with pharmaceutical standards essential for oncology therapeutics.

Product Description

HERTRAZ 440 MG (Trastuzumab Injection) is a targeted biopharmaceutical product used in the treatment of HER2-positive breast cancer and gastric cancers. Trastuzumab is a monoclonal antibody that specifically binds to the HER2 receptors on the surface of cancer cells, inhibiting proliferation and inducing immune-mediated cytotoxicity. This injection is designed for intravenous administration under the guidance of oncologists and healthcare professionals in clinical and hospital settings. HERTRAZ 440 MG plays a critical role in improving survival rates and reducing tumor progression in eligible patients with HER2 overexpressing tumors. The product is manufactured under stringent quality control and complies with pharmaceutical standards essential for oncology therapeutics.

Description provided by Trigen Enterprises.

Specifications

Molecular Weight Approximately 145 kDa
pH Approximately 6.0
Volume per Vial 50 ml solution containing 440 mg trastuzumab
Shelf Life 24 months from manufacturing date
Excipients Histidine, trehalose, polysorbate 20, water for injection
Storage Instructions Protect from light and do not freeze
Manufacturing Compliance Produced in GMP-certified facility

Use cases

Category Pharmaceuticals > Oncology Drugs > Targeted Cancer Therapies > Monoclonal Antibodies
Primary application Wholesale, distribution, and international sourcing
Brand Not specified
Product type Product

Logistics & handling

Lead time On request
Packaging As per buyer requirement
Storage condition As recommended by supplier
Origin India
Form As listed by supplier

Commercials (this seller)

Minimum order 1 Centimetre
Lead time On request
Payment terms As per negotiated commercial agreement.
Buyer questions

Frequently asked by buyers

Common questions B2B buyers ask before sourcing HERTRAZ 440 MG (TRASTUZUMAB INJECTION). Answers compiled from verified sellers' commercial terms and platform data.

Q: What specific types of cancer can HERTRAZ 440 MG treat?
A: HERTRAZ 440 MG is indicated for the treatment of HER2-positive breast cancer and HER2-positive gastric cancer.
Q: How should HERTRAZ 440 MG be stored to maintain efficacy?
A: HERTRAZ 440 MG should be stored refrigerated between 2°C to 8°C, protected from light, and must not be frozen.
Q: Is HERTRAZ 440 MG suitable for self-administration?
A: No, HERTRAZ 440 MG must be administered intravenously under the supervision of qualified healthcare professionals in a clinical setting.
Q: What is the mechanism through which HERTRAZ 440 MG works on cancer cells?
A: HERTRAZ 440 MG works as a monoclonal antibody that binds to HER2 receptors on cancer cells, blocking growth signals and activating immune system mechanisms to destroy these cells.
Q: Can HERTRAZ 440 MG be used interchangeably with other trastuzumab brands?
A: HERTRAZ 440 MG is a biosimilar product; however, interchangeability should be determined by the healthcare provider considering patient condition and regulatory approvals.
Question not answered? Ask sellers directly — typical response within 4 hours.

What similar products are available in this category?

Browse all in category

More from Trigen Enterprises

View all →
mytera 500 mg (abiraterone acetate tablets)
mytera 500 mg (abiraterone acetate tablets)
$ 46.48 MOQ 1 Centimetre
View Product
HERTRAZ 440 MG (TRASTUZUMAB INJECTION)
HERTRAZ 440 MG (TRASTUZUMAB INJECTION)
₹ 164.37/Centimetre · MOQ 1Centimetre